• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Evaluation of SARS-CoV-2 antibody persistence and viral spread in stool: a long-term care experience before COVID-19 vaccination.评估 SARS-CoV-2 抗体持久性和粪便中的病毒传播:COVID-19 疫苗接种前的长期护理经验。
Ir J Med Sci. 2023 Feb;192(1):263-268. doi: 10.1007/s11845-022-03095-7. Epub 2022 Jul 12.
2
[Shedding of SARS-CoV-2 Virus in COVID-19 Patients and Neutralizing Antibody Level].[新型冠状病毒肺炎患者严重急性呼吸综合征冠状病毒2病毒脱落情况及中和抗体水平]
Mikrobiyol Bul. 2022 Jul;56(3):416-431. doi: 10.5578/mb.20229704.
3
Longitudinal serologic and viral testing post-SARS-CoV-2 infection and post-receipt of mRNA COVID-19 vaccine in a nursing home cohort-Georgia, October 2020‒April 2021.2020 年 10 月至 2021 年 4 月,佐治亚州养老院队列中 SARS-CoV-2 感染后及接受 mRNA COVID-19 疫苗后的纵向血清学和病毒学检测。
PLoS One. 2022 Oct 27;17(10):e0275718. doi: 10.1371/journal.pone.0275718. eCollection 2022.
4
Evaluating immunity to SARS-CoV-2 in nursing home residents using saliva IgG.使用唾液 IgG 评估养老院居民对 SARS-CoV-2 的免疫力。
J Am Geriatr Soc. 2022 Mar;70(3):659-668. doi: 10.1111/jgs.17660. Epub 2022 Jan 22.
5
Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign.在 COVID-19 疫苗接种运动初期,比利时养老院居民和工作人员中 SARS-CoV-2 抗体的流行情况。
Eur J Gen Pract. 2023 Dec;29(2):2149732. doi: 10.1080/13814788.2022.2149732. Epub 2022 Nov 28.
6
Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 long-term care facilities (VIVALDI): a prospective cohort study.100 家长期护理机构(VIVALDI)中员工和居民的 SARS-CoV-2 感染率根据基线抗体状况:一项前瞻性队列研究。
Lancet Healthy Longev. 2021 Jun;2(6):e362-e370. doi: 10.1016/S2666-7568(21)00093-3. Epub 2021 Jun 3.
7
Pronounced antibody elevation after SARS-CoV-2 BNT162b2 mRNA booster vaccination in nursing home residents.在养老院居民中,接种 SARS-CoV-2 BNT162b2 mRNA 加强针后抗体明显升高。
Influenza Other Respir Viruses. 2022 Nov;16(6):1066-1071. doi: 10.1111/irv.13030. Epub 2022 Aug 12.
8
Antibody Responses After mRNA-Based COVID-19 Vaccination in Residential Older Adults: Implications for Reopening.mRNA 新冠疫苗接种后在长期护理机构老年人中的抗体反应:对重新开放的影响。
J Am Med Dir Assoc. 2021 Aug;22(8):1593-1598. doi: 10.1016/j.jamda.2021.06.006. Epub 2021 Jun 12.
9
Declining Prevalence of SARS-CoV-2 Antibodies among Vaccinated Nursing Home Residents and Staff Six Months after the Primary BNT162b2 Vaccination Campaign in Belgium: A Prospective Cohort Study.比利时首次 BNT162b2 疫苗接种活动 6 个月后,接种疫苗的养老院居民和工作人员中 SARS-CoV-2 抗体流行率下降:一项前瞻性队列研究。
Viruses. 2022 Oct 26;14(11):2361. doi: 10.3390/v14112361.
10
Anti-SARS-CoV-2 IgG antibody after the second and third mRNA vaccinations in staff and residents in a nursing home with a previous COVID-19 outbreak in Niigata, Japan.日本新潟县一家养老院在发生 COVID-19 疫情后,对员工和居民进行第二和第三次 mRNA 疫苗接种后的抗 SARS-CoV-2 IgG 抗体。
J Infect Chemother. 2024 Feb;30(2):164-168. doi: 10.1016/j.jiac.2023.09.021. Epub 2023 Sep 20.

引用本文的文献

1
Tracking the evolution of anti-SARS-CoV-2 antibodies and long-term humoral immunity within 2 years after COVID-19 infection.追踪 COVID-19 感染后 2 年内抗 SARS-CoV-2 抗体和长期体液免疫的演变。
Sci Rep. 2024 Jun 11;14(1):13417. doi: 10.1038/s41598-024-64414-9.

评估 SARS-CoV-2 抗体持久性和粪便中的病毒传播:COVID-19 疫苗接种前的长期护理经验。

Evaluation of SARS-CoV-2 antibody persistence and viral spread in stool: a long-term care experience before COVID-19 vaccination.

机构信息

Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.

Division of Medical Virology, Department of Medical Microbiology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey.

出版信息

Ir J Med Sci. 2023 Feb;192(1):263-268. doi: 10.1007/s11845-022-03095-7. Epub 2022 Jul 12.

DOI:10.1007/s11845-022-03095-7
PMID:35829907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9277604/
Abstract

BACKGROUND

Due to elderly residents, nursing homes/assisted living facilities were the most affected places in COVID-19 pandemic. Besides symptomatic patients, asymptomatic patients were detected during routine screening.

AIM

This study aims to determine the factors that affect antibody response and viral shedding in stool samples after natural exposure to the virus in residents and staff who recovered from COVID-19 before the vaccine was available.

METHODS

This prospective cross-sectional study was conducted at the nation's highest-capacity Residential and Nursing Home. Blood samples were collected between December 15, 2020 and January 15, 2021 from participating residents and staff for anti-SARS-CoV-2 antibody testing. Stool samples were obtained for SARS-CoV-2 PCR testing 2 months after COVID-19. The Social Sciences (SPSS) program version 15.0 was used for statistical analysis. The Mann-Whitney U test compared SARS-CoV-2 antibody concentration between two groups.

RESULTS

Four hundred sixty-four (52.3%) residents and 424 (47.7%) staff participated. Entirely 259 (29.2%) participants were anti-SARS-CoV-2 IgG (+) and 255 (28.7%) were SARS-CoV-2 PCR (+). Both antibody and PCR positivity was detected in 196 (76.9%). In PCR (-) group, 63 (10.0%) participants were SARS-CoV-2 IgG (+). Antibody titers were found highest in SARS-CoV-2 PCR (+) male residents. SARS-CoV-2 IgG titers were significantly high in SARS-CoV-2 PCR (+) and hospitalized participants regardless of age. Stool samples were obtained from 61(23.9%) participants and were found negative.

CONCLUSION

A durable SARS-CoV-2 IgG antibody response was monitored at least 9 months after the participants were diagnosed with COVID-19. SARS-CoV-2 antibody positivity was detected 76.9% in PCR (+) and 10.0% in PCR (-) participants. Knowing the duration of detectable antibodies is an important finding for developing disease prevention and public health strategies.

摘要

背景

由于老年居民的存在,养老院/辅助生活设施是 COVID-19 大流行期间受影响最大的地方。除了有症状的患者外,无症状患者也在常规筛查中被发现。

目的

本研究旨在确定在疫苗可用之前从 COVID-19 中康复的居民和工作人员在自然暴露于病毒后,影响粪便样本中抗体反应和病毒脱落的因素。

方法

这项前瞻性的横断面研究在全国容量最大的住宅和养老院进行。于 2020 年 12 月 15 日至 2021 年 1 月 15 日期间采集参与居民和工作人员的血液样本进行抗 SARS-CoV-2 抗体检测。COVID-19 后 2 个月采集粪便样本进行 SARS-CoV-2 PCR 检测。采用社会科学(SPSS)程序 15.0 进行统计分析。Mann-Whitney U 检验比较两组 SARS-CoV-2 抗体浓度。

结果

464 名(52.3%)居民和 424 名(47.7%)工作人员参与了研究。共有 259 名(29.2%)参与者抗 SARS-CoV-2 IgG(+),255 名(28.7%)为 SARS-CoV-2 PCR(+)。两者均阳性者 196 例(76.9%)。PCR(-)组中,63 名(10.0%)参与者 SARS-CoV-2 IgG(+)。PCR(+)男性居民的 SARS-CoV-2 抗体滴度最高。无论年龄大小,SARS-CoV-2 PCR(+)和住院患者的 SARS-CoV-2 IgG 滴度均显著升高。从 61 名(23.9%)参与者中获得粪便样本,结果均为阴性。

结论

至少在参与者被诊断为 COVID-19 后 9 个月监测到持续的 SARS-CoV-2 IgG 抗体反应。PCR(+)参与者中 SARS-CoV-2 抗体阳性率为 76.9%,PCR(-)参与者中 SARS-CoV-2 抗体阳性率为 10.0%。了解可检测抗体的持续时间是制定疾病预防和公共卫生策略的重要发现。